AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-positioned,” while Novartis and Roche look more at risk, ...

The newly formed biotech launches with five promising autoimmune candidates, $300 million in funding, and leadership from ...

Eleven New Jersey hospitals, including Hackensack University Medical Center, are celebrated for excellence in healthcare, ...

As Keytruda generic competition looms larger on the horizon, the company is hoping to reinvest the savings into pipeline ...